CCL2 and pancreatic ductal adenocarcinoma: One report indicated that in pancreatic ductal adenocarcinoma (PDAC), HIF-1α promoted the secretion of MCP-1, enhanced monocyte and macrophage recruitment, and strengthened inflammation and fibrosis [11].